BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
G-protein-coupled receptor binding
,
Pseudomonas infection
,
Adipose tissue
,
BRCA1
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
rna binding protein ews
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
No genes found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
No biogroups found
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
Ewing sarcoma A673 cell line with HNRNPK knockdown
Ewing sarcoma A-673 cells with shRNA knockdown of EWS-FLI1 fusion protein
Ewing's sarcoma of bone TC71 cells with CRISPR-CAS9 mediated ID2 knockout & rescue by re-expression
RNA immunoprecipitation (RIP-Chip) analysis for EWS-bound mRNA in HeLa cells
Prostate epithelial RWPE-1 cells expressing wildtype ERG, ERG-P436A mutant and/or EWS shRNA
Explore Curated Studies Results
Literature
Most Relevant Literature
The ETS transcription factor ETV6 constrains the transcriptional activity of EWS-FLI to promote Ewin…
Identification of genes regulated by the EWS/NR4A3 fusion protein in extraskeletal myxoid chondrosar…
Inactivation of ICAM1 inhibits metastasis and improves the prognosis of Ewing's sarcoma.
Inhibition of HDACs reduces Ewing sarcoma tumor growth through EWS-FLI1 protein destabilization.
SPOP and OTUD7A Control EWS-FLI1 Protein Stability to Govern Ewing Sarcoma Growth.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Depsipeptide to Treat Patients With Cutaneous T-Cell Lymphoma and Peripheral T-Cell Lymphoma
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ